Insider Transactions in Q2 2023 at Intuitive Surgical Inc (ISRG)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2023
|
Marshall Mohr Executive VP Global Business S |
SELL
Open market or private sale
|
Direct |
11,250
-31.79%
|
$3,656,250
$325.0 P/Share
|
|
Jun 14
2023
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+24.12%
|
$663,750
$59.46 P/Share
|
|
Jun 14
2023
|
Craig H Barratt Director |
SELL
Open market or private sale
|
Direct |
1,567
-100.0%
|
$504,574
$322.78 P/Share
|
|
Jun 14
2023
|
Craig H Barratt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,567
+50.0%
|
$64,247
$41.26 P/Share
|
|
Jun 14
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
2,443
-25.18%
|
$793,975
$325.0 P/Share
|
|
Jun 14
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
2,443
+20.12%
|
$708,470
$290.33 P/Share
|
|
May 11
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-2.28%
|
$51,207
$303.47 P/Share
|
|
May 11
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
363
+4.66%
|
-
|
|
May 02
2023
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
138
-42.2%
|
-
|
|
May 01
2023
|
Craig H Barratt Director |
SELL
Open market or private sale
|
Direct |
2,000
-100.0%
|
$612,000
$306.0 P/Share
|
|
May 01
2023
|
Craig H Barratt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$82,000
$41.26 P/Share
|
|
Apr 28
2023
|
Mark J Rubash Director |
SELL
Open market or private sale
|
Direct |
7,323
-6.27%
|
$2,196,900
$300.0 P/Share
|
|
Apr 28
2023
|
Mark J Rubash Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,323
+5.85%
|
$1,237,587
$169.93 P/Share
|
|
Apr 27
2023
|
Mark J Rubash Director |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+3.02%
|
-
|
|
Apr 27
2023
|
Monica P Reed Director |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+31.73%
|
-
|
|
Apr 27
2023
|
Jami K Nachtsheim Director |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+8.69%
|
-
|
|
Apr 27
2023
|
Amy L Ladd Director |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+28.62%
|
-
|
|
Apr 27
2023
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+1.87%
|
-
|
|
Apr 27
2023
|
Keith R Leonard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+11.85%
|
-
|
|
Apr 27
2023
|
Joseph C Beery Director |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+21.1%
|
-
|
|
Apr 27
2023
|
Craig H Barratt Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
655
+2.52%
|
-
|
|
Apr 27
2023
|
Don R Kania Director |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+12.85%
|
-
|
|
Apr 27
2023
|
Amal M Johnson |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+3.95%
|
-
|
|
Apr 24
2023
|
David J. Rosa President |
SELL
Open market or private sale
|
Direct |
40,764
-20.75%
|
$12,188,436
$299.2 P/Share
|
|
Apr 24
2023
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
54,000
+21.56%
|
$2,268,000
$42.64 P/Share
|
|
Apr 21
2023
|
David J. Rosa President |
SELL
Open market or private sale
|
Direct |
40,800
-22.26%
|
$12,117,600
$297.92 P/Share
|
|
Apr 21
2023
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
54,000
+22.76%
|
$2,268,000
$42.64 P/Share
|
|
Apr 21
2023
|
Mark J Rubash Director |
SELL
Open market or private sale
|
Direct |
9,818
-3.15%
|
$2,915,946
$297.93 P/Share
|
|
Apr 21
2023
|
Mark J Rubash Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,818
+3.04%
|
$1,286,158
$131.94 P/Share
|
|
Apr 21
2023
|
Fredrik Widman VP Corporate Controller |
SELL
Open market or private sale
|
Direct |
630
-22.0%
|
$187,110
$297.87 P/Share
|
|
Apr 21
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
8,623
-11.74%
|
$2,561,031
$297.94 P/Share
|
|
Apr 21
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
6,260
+9.55%
|
$1,314,600
$210.91 P/Share
|
|
Apr 21
2023
|
Craig H Barratt Director |
SELL
Open market or private sale
|
Direct |
6,000
-100.0%
|
$1,782,000
$297.92 P/Share
|
|
Apr 21
2023
|
Craig H Barratt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+50.0%
|
$246,000
$41.26 P/Share
|
|
Apr 21
2023
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,623
-61.03%
|
$2,877,277
$299.48 P/Share
|
|
Apr 21
2023
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+38.31%
|
$1,360,000
$170.44 P/Share
|